HGH Fragment 176-191: What the Research Shows
A research-audience overview of HGH Fragment 176-191, a growth-hormone fragment studied in laboratory lipid-metabolism models. Research use only.
Read article
Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and this compound is not approved for human or veterinary use.
Phenylpiracetam hydrazide (also called Fonturacetam hydrazide) is a racetam-class compound and an analogue of phenylpiracetam in which the amide group is replaced by a hydrazide. It is studied in the nootropic research literature in laboratory cognition models.
The evidence base is preclinical, based on animal and cell studies. Human data are limited, so findings should not be extrapolated to people.
Phenylpiracetam hydrazide is supplied as a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption. Note that phenylpiracetam itself is prohibited in competitive sport.
Keep the product cool, dry and away from light, and follow the documentation supplied with each batch.
It is studied in laboratory cognition models as a racetam-class analogue of phenylpiracetam.
No. It is a research compound only and is not intended for human or veterinary use.
Phenylpiracetam hydrazide is a racetam-class nootropic research compound studied in preclinical cognition models. It is a research material only. Review the Phenylpiracetam hydrazide research product.
Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.
A research-audience overview of HGH Fragment 176-191, a growth-hormone fragment studied in laboratory lipid-metabolism models. Research use only.
Read articleA research-audience overview of Oxytocin, a naturally occurring neuropeptide studied in laboratory social-behaviour and receptor models. Research use only.
Read articleA research-audience overview of SR-9009 (Stenabolic), a REV-ERB agonist studied in laboratory circadian and metabolic models, including its regulatory status. Research use only.
Read article